Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
Actinogen Medical Ltd banner

Actinogen Medical Ltd
ASX:ACW

Watchlist Manager
Actinogen Medical Ltd Logo
Actinogen Medical Ltd
ASX:ACW
Watchlist
Price: 0.042 AUD
Market Cap: AU$134.1m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

ACW Price Targets Summary
Actinogen Medical Ltd

Wall Street analysts forecast ACW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACW is 0.082 AUD with a low forecast of 0.081 AUD and a high forecast of 0.084 AUD.

ACW Lowest Forecast
Wall Street Target
0.081 AUD
92% Upside
ACW Average Forecast
Wall Street Target
0.082 AUD
94% Upside
ACW Highest Forecast
Wall Street Target
0.084 AUD
100% Upside
Lowest
Price Target
0.081 AUD
92% Upside
Average
Price Target
0.082 AUD
94% Upside
Highest
Price Target
0.084 AUD
100% Upside
Actinogen Medical Ltd Competitors:
Price Targets
NSIT
Insight Enterprises Inc
62% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
24% Upside
HOTH
Hoth Therapeutics Inc
400% Upside
8961
Mori Trust Sogo Reit Inc
-3% Downside
NSIT
Insight Enterprises Inc
62% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
24% Upside
HOTH
Hoth Therapeutics Inc
400% Upside
8961
Mori Trust Sogo Reit Inc
-3% Downside
VINP
Vinci Partners Investments Ltd
16% Upside
INO
Inovio Pharmaceuticals Inc
442% Upside

Revenue
Forecast

19% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss
19% / Year
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-96%
Average Miss

For the last 14 years the compound annual growth rate for Actinogen Medical Ltd's revenue is 19%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-40%
Average Miss

What are analyst estimates?

See Also

Summary
ACW intrinsic value, competitors valuation, and company profile.
DCF Valuation
ACW stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ACW stock valuation using valuation multiples.
Wall Street Estimates
ACW price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ACW stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACW's stock price target?
Price Target
0.082 AUD

According to Wall Street analysts, the average 1-year price target for ACW is 0.082 AUD with a low forecast of 0.081 AUD and a high forecast of 0.084 AUD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 318,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.